Navigation Links
Applied Biosystems Introduces Advanced Gene Expression Service Provider Program

Applied Biosystems (NYSE:ABI), an Applera Corporation business, today announced the introduction of the Applied Biosystems Advanced Gene Expression Service Provider Program, a new program for service providers who are interested in accessing Applied Biosystems comprehensive solution for gene expression analysis, including the highly sensitive Expression Array System for whole genome analysis and gold-standard TaqMan® Gene Expression Assays for target validation. The program includes a bundled product option for the entire gene expression workflow application and technical and promotional support that is expected to enhance service providers?business offerings.

The program, intended to assist service providers in genetic analysis using interpretation tools and content to advance scientific research while helping them achieve necessary return on investment, was announced today in advance of this weekend’s annual World Microarray Congress in Vancouver, Canada.

The Applied Biosystems Expression Array System forms the technical platform for the program and can be optionally bundled with companion products that comprise Applied Biosystems?whole solution for gene expression analysis, including microarrays for human, mouse, and rat, TaqMan® Gene Expression Assays, and Real-Time PCR Systems.

Additional data analysis and promotional support is included with the Applied Biosystems Advanced Gene Expression Service Provider Program. Participants will have access to the Celera Discovery System?Online Platform and Panther?Protein Classification System, a Service Provider web link on the Applied Biosystems Web site, and on-site seminars to educate customers to help provide increased business opportunities.

“Under the program, organizations offering gene expression analysis services can now offer their clients a complete gene expression analysis system backed with technical and promotional support package from the leader in gene expression technologies ,?said Catherine M. Burzik, President of Applied Biosystems.

The Applied Biosystems Expression Array System is a highly sensitive gene expression detection system. The system detects more genes and achieves more than a 10-fold increase in sensitivity while using less sample for the detection of genes expressed at very low levels compared with conventional fluorescent microarrays. The system uses a chemiluminescence-detection instrument, software, and chemistries to deliver unambiguous gene results that are highly sensitive and reproducible.

The PCR process and the 5' nuclease detection process are covered by patents owned by Roche Molecular System, Inc. and F. Hoffmann-La Roche Ltd ("Roche"). Performing services using these patented processes may require additional licenses from Applied Biosystems or Roche.

For more information, visit http://docs.appliedbiosystems.com/pebiodocs/00114098.pdf


'"/>

Source:Applied Biosystems


Related biology news :

1. Applied scientists create wrinkled skin on polymers
2. Agilent Technologies Introduces First Commercial Mouse Microarray for Comparative Genomic Hybridization Research
3. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
4. Advanced genomics and proteomics improve the diagnosis and treatment of a deadly lung disease
5. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
6. Iron Deficiency Sparks Dramatic Changes In Gene Expression
7. Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses
8. Gene Expression in the Aging Brain
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/3/2017)... Onitor, provider of digital health technology for ... innovative biometric data-driven program designed to aid weight loss ... 2017 Consumer Electronics Show (CES) in Las ... the World Health Organization (WHO), have identified lifestyle risks ... are overweight or obese. WHO also states that more ...
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016 /PRNewswire/ ... que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado que ... de tumor en 2017, con múltiples sitios previstos a lo largo ... ... en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que ...
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, Inc. ... genomics technology company, announced today that on December 13, ... Department of The Nasdaq Stock Market LLC which acknowledged ... price of WaferGen,s common stock had been at $1.00 ... has regained compliance with Listing Rule 5550(a)(2) of the ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... ... January 18, 2017 , ... LabRoots , ... from around the world, was today awarded the "Best Science & Technology Social ... on merit and decided upon by a dedicated team of researchers and analysts. ...
(Date:1/19/2017)... 18, 2017  Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ("NW ... therapies for operable and inoperable solid tumor cancers, announced ... Officer of NW Bio, will present at the Phacilitate ... the Hyatt Regency Hotel in Miami, Florida ... session entitled "New Therapeutic Approaches – Expanding the Reach ...
(Date:1/18/2017)... , January 18, 2017 According to a new market ... Neuroscience, Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, Academic and Research ... to reach USD 739.9 Million by 2021 from USD 557.1 Million in 2016, ... ... MarketsandMarkets Logo ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... Ops Executives 2017 in its continued commitment to the advancement of the clinical ... discuss current issues related to clinical trial planning and management. , As ...
Breaking Biology Technology: